Viveve Medical, Inc. (NASDAQ:VIVE – Get Rating) was the recipient of a significant decrease in short interest in the month of March. As of March 31st, there was short interest totalling 98,100 shares, a decrease of 22.1% from the March 15th total of 125,900 shares. Currently, 1.0% of the company’s stock are sold short. Based on an average daily volume of 182,700 shares, the short-interest ratio is presently 0.5 days.
VIVE has been the topic of several research reports. Alliance Global Partners dropped their price objective on shares of Viveve Medical to $5.25 in a report on Friday, March 18th. Zacks Investment Research upgraded shares of Viveve Medical from a “sell” rating to a “hold” rating in a report on Wednesday, January 12th.
Shares of NASDAQ VIVE opened at $1.04 on Monday. The firm’s 50-day moving average price is $0.97 and its 200-day moving average price is $1.39. Viveve Medical has a 1-year low of $0.78 and a 1-year high of $3.22. The firm has a market capitalization of $11.04 million, a P/E ratio of -0.39 and a beta of 0.63. The company has a current ratio of 4.91, a quick ratio of 4.58 and a debt-to-equity ratio of 0.34.
Several large investors have recently bought and sold shares of the company. Virtu Financial LLC increased its position in shares of Viveve Medical by 234.1% during the fourth quarter. Virtu Financial LLC now owns 35,028 shares of the company’s stock worth $40,000 after acquiring an additional 24,543 shares in the last quarter. Millennium Management LLC bought a new stake in shares of Viveve Medical during the fourth quarter worth about $32,000. Citadel Advisors LLC bought a new stake in shares of Viveve Medical during the fourth quarter worth about $32,000. Renaissance Technologies LLC bought a new stake in shares of Viveve Medical during the fourth quarter worth about $66,000. Finally, Dimensional Fund Advisors LP grew its position in Viveve Medical by 84.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 30,622 shares of the company’s stock worth $35,000 after purchasing an additional 13,977 shares in the last quarter. 17.64% of the stock is owned by institutional investors.
Viveve Medical Company Profile (Get Rating)
Viveve Medical, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components.
- Get a free copy of the StockNews.com research report on Viveve Medical (VIVE)
- Institutions And Analysts Drive UnitedHealth Group Higher
- MarketBeat: Week in Review 4/11 – 4/15
- Three Beaten Down Mega Caps The Analysts Are Upgrading
- Top 3 Safe Stocks for Conservative Investors
- Array Technologies Stock Giving Another Ground Floor Entry
Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.